Cargando…

Cognitive Impairment and Electroconvulsive Therapy in Geriatric Depression, What Could be the Role of Rivastigmine? A Case Series

Electroconvulsive therapy (ECT), albeit highly effective in treating depression, is frequently associated with cognitive impairment, either temporary or more persistent. Especially in older patients, who generally respond even better, serious cognitive impairment during the course of ECT may lead to...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Schaik, Audrey Monica, Rhebergen, Didi, Henstra, Marieke Jantien, Kadouch, Daniel J., van Exel, Eric, Stek, Maximilianus Lourentius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653751/ https://www.ncbi.nlm.nih.gov/pubmed/26664715 http://dx.doi.org/10.4081/cp.2015.780

Ejemplares similares

Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome
por: van Zutphen, Elisabeth Maria, et al.
Publicado: (2019)

Hypochondriacal delusion in an elderly woman recovers quickly with electroconvulsive therapy
por: Dols, Annemieke, et al.
Publicado: (2012)

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods
por: Henstra, Marieke J., et al.
Publicado: (2022)

The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression
por: Loef, Dore, et al.
Publicado: (2021)

Psychosocial and Health-Related Factors Associated With Discordance Between 13-Year Trajectories of Self-Reported Functional Limitations and Performance-Based Physical Functioning in Old Age
por: Kok, Almar A. L., et al.
Publicado: (2019)

Pharmacological prevention of postictal agitation after electroconvulsive therapy—A systematic review and meta-analysis
por: Feenstra, Thomas C., et al.
Publicado: (2023)

Esophagectasis Related to Rivastigmine
por: Sasaki, Osamu, et al.
Publicado: (2019)

Rivastigmine in the treatment of Alzheimer’s disease: an update
por: Onor, Maria Luisa, et al.
Publicado: (2007)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Acquired Localized Hypertrichosis Induced by Rivastigmine
por: Imbernón-Moya, Adrian, et al.
Publicado: (2016)

Electroconvulsive Therapy for Geriatric Depression in the COVID-19 Era: Reflection on the Ethics
por: Burhan, Amer M., et al.
Publicado: (2020)

GIS as a heuristic tool to interpret ancient historiography: A case study to reconstruct what could plausibly have happened according to the accounts in New Testament texts
por: van Altena, Vincent, et al.
Publicado: (2021)

Exploring resting state connectivity in patients with psychotic depression
por: Oudega, Mardien L., et al.
Publicado: (2019)

An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Mok, Vincent, et al.
Publicado: (2007)

Effects of rivastigmin tartarat in the therapy of patients with schizophrenia
por: Djordjevic, Snezana, et al.
Publicado: (2010)

Direct Asymmetric Reductive Amination for the Synthesis of (S)-Rivastigmine
por: Gao, Guorui, et al.
Publicado: (2018)

Treatment of pediatric antimuscarinic delirium with oral rivastigmine
por: Yakey, Brandtly, et al.
Publicado: (2023)

Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life
por: Annicchiarico, Roberta, et al.
Publicado: (2007)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Electroconvulsive Therapy - What Do Patients Think Of Their Treatment?
por: Maguire, S, et al.
Publicado: (2016)

Development and Validation of a Spectrofluorimetric Method for the Estimation of Rivastigmine in Formulations
por: Kapil, R., et al.
Publicado: (2009)

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia
por: Oh, Yoon-Sang, et al.
Publicado: (2015)

Preparation and Characterization of Rivastigmine Transdermal Patch Based on Chitosan Microparticles
por: Sadeghi, Mohsen, et al.
Publicado: (2016)

Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease
por: dos Santos, Gustavo Alves Andrade, et al.
Publicado: (2011)

Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
por: Kondak, Constantin, et al.
Publicado: (2023)

Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study
por: Tsuno, Norifumi, et al.
Publicado: (2019)

Autism and depression are connected: A report of two complimentary network studies
por: van Heijst, Barbara FC, et al.
Publicado: (2019)

Pain in dementia: prevalence and associated factors: protocol of a multidisciplinary study
por: van Kooten, Janine, et al.
Publicado: (2015)

Critical Illness–induced Corticosteroid Insufficiency: What It Is Not and What It Could Be
por: Téblick, Arno, et al.
Publicado: (2022)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice
por: Seibert, Johannes, et al.
Publicado: (2012)

Third degree atrioventricular block associated with treatment with rivastigmine transdermal patch
por: Knudtzen, Fredrikke C., et al.
Publicado: (2013)

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits
por: Perrotta, Gaetano, et al.
Publicado: (2017)

Adverse drug events affecting medication persistence with rivastigmine patch application
por: Osada, Takashi, et al.
Publicado: (2018)

Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina
por: Bezerra da Silva, Cristiane, et al.
Publicado: (2016)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
por: Ray, Balmiki, et al.
Publicado: (2020)

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
por: Jamshidnejad-Tosaramandani, Tahereh, et al.
Publicado: (2021)

Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
por: Shimura, Hideki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mmsb01ok44faat85m5or28hmur